Metformin Protects H9C2 Cardiomyocytes from High-Glucose and Hypoxia/Reoxygenation Injury via Inhibition of Reactive Oxygen Species Generation and Inflammatory Responses: Role of AMPK and JNK

Metformin is a first-line drug for the management of type 2 diabetes. Recent studies suggested cardioprotective effects of metformin against ischemia/reperfusion injury. However, it remains elusive whether metformin provides direct protection against hypoxia/reoxygenation (H/R) injury in cardiomyocy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Diabetes Res
Main Authors: Hu, Mingyan, Ye, Ping, Liao, Hua, Chen, Manhua, Yang, Feiyan
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884853/
https://ncbi.nlm.nih.gov/pubmed/27294149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/2961954
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados